It has also been demonstrated that inhibition of GSK3β can reduce the accumulation of Aβ in the body to a certain extent and can alleviate the reduction of spatial learning and memory in transgenic animals with Alzheimer’s disease (Ding et al., 2008). This evidence concerns the gene GSK3B and Alzheimer disease.